The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
Open accessAbstract
Genes mutated in patients with Fanconi anemia (FA) interact with the DNA repair genes BRCA1 and BRCA2/FANCD1 to suppress tumorigenesis, but the molecular functions ascribed to them cannot fully explain all of their cellular roles. Here, we show a repair-independent requirement for FA genes, including FANCD2, and BRCA1 in protecting stalled replication forks from degradation. Fork protection is surprisingly rescued in FANCD2-deficient cells by elevated RAD51 levels or stabilized RAD51 filaments. Moreover, FANCD2-mediated fork protection is epistatic with RAD51 functions, revealing an unanticipated fork protection pathway that connects FA genes to RAD51 and the BRCA1/2 breast cancer suppressors. Collective results imply a unified molecular mechanism for repair-independent functions of FA, RAD51, and BRCA1/2 proteins in preventing genomic instability and suppressing tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BRCA1 is implicated in a repair-independent mechanism in protecting stalled replication forks from degradation to maintain genome stability (Schlacher et al., 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
In the citing paper
“As previously shown, BRCA1-deficient cells show significant shortening of fork length following hydroxyurea (HU) treatment indicating degradation of stalled replication forks.”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
In the citing paper
“In addition, Abraxas did not appear to be required for efficient replication restart after HU treatment (data not shown), consistent with published observation that BRCA1 is not required for replication recovery (Schlacher et al., 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Schlacher et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,292
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Self-citationInteraction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858
Advanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G. E., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 635
How the Fanconi Anemia Pathway Guards the Genome
Moldovan, G., & D’Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 601
Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis
Hashimoto, Y., Chaudhuri, A. R., Lopes, M., & Costanzo, V. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1927 · Cited by 537
The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
Knipscheer, P., Räschle, M., Smogorzewska, A., Enoiu, M., Ho, T. V., Schärer, O. D., Elledge, S. J., & Walter, J. C. (2009) · Science · doi:10.1126/science.1182372 · Cited by 525
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Schroeder, 1964, [Spontaneous chromosome aberrations in familial panmyelopathy], Humangenetik, 1, 194
Cited by
Sorted by citations
Items 501–600 of 930
Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects
Varga, D., Deniz, M., Schwentner, L., & Wiesmüller, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14010640 · Cited by 23
Hu, L., Huang, W., Hjort, E. E., Bei, L., Platanias, L. C., & Eklund, E. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681361 · Cited by 23
A mechanism for 1,4-Benzoquinone-induced genotoxicity
Son, M., Deng, C., Hoeijmarkers, J. H., Rebel, V. I., & Hasty, P. (2016) · Oncotarget · doi:10.18632/oncotarget.10184 · Cited by 23
PARPi focus the spotlight on replication fork protection in cancer
Schlacher, K. (2017) · Nature Cell Biology · doi:10.1038/ncb3638 · Cited by 23
Self-citationHeitmeir, B., Deniz, M., Janni, W., Rack, B. K., Schochter, F., & Wiesmüller, L. (2022) · Cancers · doi:10.3390/cancers14040997 · Cited by 23
Said, M., Barra, V., Balzano, E., Talhaoui, I., Pelliccia, F., Giunta, S., & Naim, V. (2022) · Communications Biology · doi:10.1038/s42003-022-04360-2 · Cited by 22
Liu, W., Polaczek, P., Roubal, I., Meng, Y., Choe, W., Caron, M., Sedgeman, C. A., Yu, X., Liu, C., Wu, Q., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad624 · Cited by 24
SNM1B/Apollo in the DNA damage response and telomere maintenance
Schmiester, M., & Demuth, I. (2017) · Oncotarget · doi:10.18632/oncotarget.16864 · Cited by 24
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells
Duan, H., Mansour, S., Reed, R., Gillis, M. K., Parent, B., Liu, B., Sztupinszki, Z. M., Birkbak, N. J., Szállási, Z., Elia, A. E. H., et al. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201908192 · Cited by 22
Genome-wide CRISPR screens reveal cyclin C as synthetic survival target of BRCA2
Tang, M., Pei, G., Su, D., Wang, C., Feng, X., Srivastava, M., Chen, Z., Zhao, Z., & Chen, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab540 · Cited by 22
Bénureau, Y., Pouvelle, C., Dupaigne, P., Baconnais, S., Tavares, E. M., Mazón, G., Despras, E., Cam, É. L., & Kannouche, P. L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac746 · Cited by 22
Dimitrov, S. D., Lu, D., Naetar, N., Hu, Y., Pathania, S., Kanellopoulou, C., & Livingston, D. M. (2013) · Genes & Development · doi:10.1101/gad.225045.113 · Cited by 22
FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation
Wang, J., Jo, U., Joo, S. Y., & Kim, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9595 · Cited by 21
Non-Recombinogenic Functions of Rad51, BRCA2, and Rad52 in DNA Damage Tolerance
Prado, F. (2021) · Genes · doi:10.3390/genes12101550 · Cited by 23
Meyer, F., Engel, A. M., Krause, A. K., Wagner, T., Poole, L., Dubrovska, A., Peitzsch, C., Rothkamm, K., Petersen, C., & Borgmann, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.765284 · Cited by 21
FANCD2-dependent mitotic DNA synthesis relies on PCNA K164 ubiquitination
Leung, W., Baxley, R. M., Traband, E. L., Chang, Y., Rogers, C. B., Wang, L., Durrett, W., Bromley, K., Fiedorowicz, L., Thakar, T., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113523 · Cited by 21
Mre11 ATLD17/18 mutation retains Tel1/ATM activity but blocks DNA double-strand break repair
Limbo, O., Moiani, D., Kertokalio, A., Wyman, C., Tainer, J. A., & Russell, P. R. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks954 · Cited by 22
Biochemical and cell biological assays to identify and characterize DNA helicase inhibitors
Banerjee, T., Aggarwal, M., Sommers, J. A., & Brosh, R. M. (2016) · Methods · doi:10.1016/j.ymeth.2016.04.007 · Cited by 21
Advances in structural studies of recombination mediator proteins
Korolev, S. (2016) · Biophysical Chemistry · doi:10.1016/j.bpc.2016.12.001 · Cited by 21
A Novel Cell-Penetrating Antibody Fragment Inhibits the DNA Repair Protein RAD51
Pastushok, L., Fu, Y., Lin, L. S., Luo, Y., DeCoteau, J. F., Lee, K. C. L., & Geyer, C. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-47600-y · Cited by 21
Structural insight into FANCI–FANCD2 monoubiquitination
Li, L., Tan, W., & Deans, A. J. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200001 · Cited by 22
TIPIN depletion leads to apoptosis in breast cancer cells
Baldeyron, C., Brisson, A., Tesson, B. M., Némati, F., Koundrioukoff, S., Saliba, E., de Koning, L., Martel, E., Ye, M., Rigaill, G. J., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.010 · Cited by 23
Disparate requirements for RAD54L in replication fork reversal
Uhrig, M. E., Sharma, N., Maxwell, P., Gómez, J., Selemenakis, P., Mazin, A. V., & Wiese, C. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae828 · Cited by 20
Hwang, T., Sitko, L. K., Khoirunnisa, R., Aguad, F. N., Samuel, D. M., Park, H., Cheon, B., Mutsnaini, L., Lee, J., Otlu, B., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1122 · Cited by 21
Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know
Khoury, R. A., Sauter, S. L., Kovacic, M. B., Nelson, A., Myers, K. C., Mehta, P. A., Davies, S. M., & Wells, S. I. (2018) · Viruses · doi:10.3390/v10010047 · Cited by 20
Liang, F., & Jin, F. (2019) · Oncology Letters · doi:10.3892/ol.2019.10046 · Cited by 20
Pulver, E. M., Mukherjee, C., van de Kamp, G., Roobol, S. J., Rother, M. B., van der Gulden, H. M. L., de Bruijn, R., Lattanzio, M. V., van der Burg, E., Drenth, A. P., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1415 · Cited by 20
Mani, C., Tripathi, K. K., Omy, T. R., Reedy, M. B., Manne, U., & Palle, K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166300 · Cited by 20
Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors
Piombino, C., & Cortesi, L. (2022) · Cancers · doi:10.3390/cancers14112804 · Cited by 21
BRCA1/2 Haploinsufficiency: Exploring the Impact of Losing one Allele
Minello, A., & Carreira, A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168277 · Cited by 20
FANCM branchpoint translocase: Master of traverse, reverse and adverse DNA repair
Abbouche, L., Bythell‐Douglas, R., & Deans, A. J. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103701 · Cited by 20
To the Rescue: The Fanconi Anemia Genome Stability Pathway Salvages Replication Forks
Moldovan, G., & D’Andrea, A. D. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.006 · Cited by 22
Xie, M., Park, D., You, S., Li, R., Owonikoko, T. K., Wang, Y., Doetsch, P. W., & Deng, X. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1358 · Cited by 20
Activation of the FA pathway mediated by phosphorylation and ubiquitination
Ishiai, M., Sato, K., Tomida, J., Kitao, H., Kurumizaka, H., & Takata, M. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.05.003 · Cited by 20
Mochizuki, A. L., Katanaya, A., Hayashi, E., Hosokawa, M., Moribe, E., Motegi, A., Ishiai, M., Takata, M., Kondoh, G., Watanabe, H., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00117-17 · Cited by 20
Observation and Analysis of RAD51 Nucleation Dynamics at Single-Monomer Resolution
Subramanyam, S. V., Kinz-Thompson, C. D., Gonzalez, R. L., & Spies, M. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.12.008 · Cited by 22
Balcerek, J., Jiang, J. T., Li, Y., Jiang, Q., Holdreith, N., Singh, B. B., Chandra, V., Lv, K., Ren, J., Rozenova, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06380-1 · Cited by 21
Xu, X., Chen, E. S., Mo, L., Zhang, L., Shao, F., Miao, K., Liu, J., Su, S. M., Valecha, M. V., Chan, U. I., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy398 · Cited by 20
Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance
Zhao, Y., & Chen, S. (2019) · Current Drug Targets · doi:10.2174/1389450120666190222181857 · Cited by 20
Ercilla, A., Feu, S., Aranda, S., Llopis, A., Brynjólfsdóttir, S. H., Sørensen, C. S., Toledo, L. I., & Agell, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03206-1 · Cited by 21
Chakraborty, S., Singh, M. K., PANDITA, R. K., Singh, V., Lo, C. S. Y., Leonard, F., Horikoshi, N., Moros, E. G., Guha, D., Hunt, C. R., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104142 · Cited by 21
The TIP60-ATM axis regulates replication fork stability in BRCA-deficient cells
Schleicher, E. M., Dhoonmoon, A., Jackson, L. M., Khatib, J. B., Nicolae, C. M., & Moldovan, G. (2022) · Oncogenesis · doi:10.1038/s41389-022-00410-w · Cited by 20
Li, Y., Cen, Y., Tu, M., Xiang, Z., Tang, S., Lü, W., Zhang, H., & Xu, J. (2023) · Research · doi:10.34133/research.0070 · Cited by 19
What are the DNA lesions underlying formaldehyde toxicity?
Benedict, B., Kristensen, S. M., & Duxin, J. P. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103667 · Cited by 20
Thirthagiri, E., Klarmann, K. D., Shukla, A. K., Southon, E. A., Biswas, K., Martin, B. K., North, S. L., Magidson, V., Burkett, S. S., Haines, D. C., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw066 · Cited by 21
Synthetic lethality: the road to novel therapies for breast cancer
Dhillon, K. K., Bajrami, I., Taniguchi, T., & Lord, C. J. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0228 · Cited by 22
Wang, R., Lenoir, W. F., Wang, C., Su, D., McLaughlin, M. E., Hu, Q., Shen, X. H., Tian, Y., Klages-Mundt, N. L., Lynn, E. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008821117 · Cited by 21
The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target
Sharp, M. F., Bythell‐Douglas, R., Deans, A. J., & Crismani, W. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.04.023 · Cited by 20
Kyo, S., Kanno, K., Takakura, M., Yamashita, H., Ishikawa, M., Ishibashi, T., Sato, S., & Nakayama, K. (2022) · Cancers · doi:10.3390/cancers14102504 · Cited by 19
Federico, M. B., Campodónico, P. B., Paviolo, N. S., & Gottifredi, V. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.09.004 · Cited by 19
Fork Protection and Therapy Resistance in Hereditary Breast CancerPreprint
Cantor, S. B., & Calvo, J. A. (2017) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2017.82.034413 · Cited by 20
SAU, A. C., Cabrita, M. A., & Pratt, M. A. C. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0225 · Cited by 18
Kim, H., Beese‐Sims, S. E., & Colaiácovo, M. P. (2018) · Genetics · doi:10.1534/genetics.118.300823 · Cited by 18
Tissue-Specific Carcinogens as Soil to Seed BRCA1/2-Mutant Hereditary Cancers
Singh, A. K., & Yu, X. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.03.004 · Cited by 20
Rytelewski, M., Ferguson, P. J., Vareki, S. M., Figueredo, R., Vincent, M. D., & Koropatnick, J. D. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.7 · Cited by 18
The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data
Gianni, P., Matenoglou, E., Geropoulos, G., Agrawal, N., Adnani, H., Zafeiropoulos, S., Miyara, S. J., Guevara, S., Mumford, J. M., Molmenti, E. P., et al. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.08.001 · Cited by 18
Balasubramanian, S., Andreani, M., Andrade, J. G., Saha, T., Sundaravinayagam, D., Garzón, J., Zhang, W., Popp, O., Hiraga, S., Rahjouei, A., et al. (2022) · eLife · doi:10.7554/elife.75047 · Cited by 18
Elfar, G. A., Aning, O. A., Ngai, T. W., Yeo, P., Chan, J. W. K., Sim, S. H., Goh, L., Ju, Y., Phua, C. Z. J., Yeo, J. Z. Z., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae811 · Cited by 17
The DNA resection protein CtIP promotes mammary tumorigenesis
Reczek, C. R., Shakya, R., Miteva, Y., Szabolcs, M. J., Ludwig, T., & Baer, R. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8605 · Cited by 20
Zhu, C., Iwase, M., Li, Z., Wang, F., Quinet, A., Vindigni, A., & Shao, J. (2022) · Nature Communications · doi:10.1038/s41467-022-34310-9 · Cited by 16
Brunner, A., Li, Q., Fisicaro, S., Kourtesakis, A., Viiliäinen, J., Johansson, H. J., Pandey, V., Mayank, A. K., Lehtiö, J., Wohlschlegel, J. A., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.07.026 · Cited by 17
Kong, L., Cheng, C., Cheruiyot, A., Yuan, J., Yang, Y., Hwang, S., Foust, D. J., Tsao, N., Wilkerson, E., Mosammaparast, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48988-6 · Cited by 16
Ramírez-Otero, M. A., & Costanzo, V. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103738 · Cited by 17
The ZGRF1 Helicase Promotes Recombinational Repair of Replication-Blocking DNA Damage in Human Cells
Brannvoll, A., Xue, X., Kwon, Y., Kompocholi, S., Simonsen, A. K. W., Viswalingam, K. S., Gonzalez, L., Hickson, I. D., Oestergaard, V. H., Mankouri, H. W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107849 · Cited by 17
Ji, F., Zhu, X., Liao, H., Ouyang, L., Huang, Y., Syeda, M. Z., & Ying, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.906957 · Cited by 16
What is wrong with Fanconi anemia cells?
Cantor, S. B., & Brosh, R. M. (2014) · Cell Cycle · doi:10.4161/15384101.2014.980633 · Cited by 16
New origin firing is inhibited by APC/CCdh1activation in S-phase after severe replication stress
Ercilla, A., Llopis, A., Feu, S., Aranda, S., Ernfors, P., Freire, R., & Agell, N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw132 · Cited by 16
Madubata, C. J., Alireza Roshan-ghias, A., Chu, T. H., Resnick, S. J., Zhao, J., Arnes, L., Wang, J., & Rabadán, R. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0032-5 · Cited by 17
Itskoviz, D., Tamary, H., Krasnov, T., Yacobovich, J., Sahar, N., Zevit, N., Shamir, R., Ben-Bassat, O., Wiseman, Y. L., Dickman, R. M., et al. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.08.010 · Cited by 16
Murthy, P., & Muggia, F. M. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.904 · Cited by 19
Boonen, R. A. C. M., Vreeswijk, M. P. G., & van Attikum, H. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00169 · Cited by 18
Bulanova, D. R., Akimov, Y. A., Senkowski, W., Oikkonen, J., Gall-Mas, L., Timonen, S., Elmadani, M., Hynninen, J., Hautaniemi, S., Aittokallio, T. A., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj1564 · Cited by 16
Wang, S., Zheng, Q.-Y., Hong, W.-F., Tang, B., Hsu, S.-J., Zhang, Y., Zheng, X., Zeng, Z.-C., Gao, C., Ke, A., et al. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110424 · Cited by 17
Strategies for the prevention or reversal of PARP inhibitor resistance
Mitri, Z. I., Goodyear, S. M., & Mills, G. B. (2024) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2024.2393251 · Cited by 15
Genotoxicity of tetrahydrofolic acid to hematopoietic stem and progenitor cells
García-Calderón, C. B., Bejarano-García, J. A., Tinoco-Gago, I., Castro, M. J., Moreno-Gordillo, P., Piruat, J. I., Caballero‐Velázquez, T., Pérez‐Simón, J. A., & Rosado, I. V. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0089-4 · Cited by 15
Determinants of Homologous Recombination Deficiency in Pancreatic Cancer
Wattenberg, M. M., & Reiss, K. A. (2021) · Cancers · doi:10.3390/cancers13184716 · Cited by 15
Bromodomain proteins: protectors against endogenous DNA damage and facilitators of genome integrity
Lee, S. Y., Kim, J. J., & Miller, K. M. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00673-0 · Cited by 15
p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway
Guo, Y., Rall-Scharpf, M., Bourdon, J., Wiesmüller, L., & Biber, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04224-3 · Cited by 15
Sampadi, B. K., Pines, A., Munk, S., Mišovic, B., de Groot, A. J. L., van de Water, B., Olsen, J. V., Mullenders, L. H. F., & Vrieling, H. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02712-7 · Cited by 14
PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures
McNevin, C. S., Cadoo, K. A., Baird, A., Finn, S. P., & McDermott, R. (2022) · Cancers · doi:10.3390/cancers14194751 · Cited by 14
Yates, M., Marois, I., St-Hilaire, E., Ronato, D. A., Djerir, B., Brochu, C., Morin, T., Hammond-Martel, I., Gezzar-Dandashi, S., Casimir, L., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002552 · Cited by 14
Georgieva, D., Wang, N., Taglialatela, A., Jerabek, S., Reczek, C. R., Lim, P. X., Sung, J., Du, Q., Horiguchi, M., Jasin, M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114006 · Cited by 14
Self-citationPositioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer
MacGilvary, N. J., & Cantor, S. B. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103775 · Cited by 14
Song, L., Xie, H., Fan, H., Zhang, Y., Cheng, Z., Chen, J., Guo, Y., Zhang, S., Zhou, X., Li, Z., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.11.034 · Cited by 14
The ubiquitination machinery of the Fanconi Anemia DNA repair pathway
Tan, W., & Deans, A. J. (2020) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2020.09.009 · Cited by 14
DCAF14 promotes stalled fork stability to maintain genome integrity
Townsend, A., Lora, G., Engel, J. L., Tirado-Class, N., & Dungrawala, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108669 · Cited by 14
Mocanu, C., & Chan, K. (2021) · Royal Society Open Science · doi:10.1098/rsos.201932 · Cited by 14
Kolinjivadi, A. M., Sankar, H., Choudhary, R., Tay, L. S., Tan, T. Z., Murata‐Kamiya, N., Voon, D. C., Kappei, D., Hatakeyama, M., Krishnan, V., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031661 · Cited by 14
Telomere Length Is Predictive of Breast Cancer Risk inBRCA2Mutation Carriers
Þorvaldsdóttir, B., Aradóttir, M., Stefánsson, Ó. A., Böðvarsdóttir, S. K., & Eyfjord, J. E. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0946 · Cited by 14
Protection or resection: BOD1L as a novel replication fork protection factor
Higgs, M. R., & Stewart, G. S. (2016) · Nucleus · doi:10.1080/19491034.2016.1143183 · Cited by 14
Beneyton, A., Nonfoux, L., Gagné, J., Rodrigue, A., Kothari, C., Atalay, N., Hendzel, M. J., Poirier, G. G., & Masson, J. (2023) · NAR Cancer · doi:10.1093/narcan/zcad043 · Cited by 14
Repair of genomic interstrand crosslinks
Bellani, M. A., Shaik, A., Majumdar, I., Ling, C., & Seidman, M. M. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103739 · Cited by 13
Saatchi, F., & Kirchmaier, A. L. (2019) · Genetics · doi:10.1534/genetics.119.302238 · Cited by 13
Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma
Joshi, S. S., Campbell, S., Lim, J. Y., McWeeney, S. K., Krieg, A. J., Bean, Y. T., Pejovic, N., Mhawech-Fauceglia, P. Y., & Pejovic, T. B. (2020) · Oncotarget · doi:10.18632/oncotarget.27437 · Cited by 13
Ditano, J. P., Donahue, K. L., Tafe, L. J., McCleery, C. F., & Eastman, A. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-86490-x · Cited by 13
Crown, K. N., Savytskyy, O. P., Malik, S.-B., Logsdon, J. M., Jr., Williams, R. S., Tainer, J. A., & Zolan, M. E. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.007906 · Cited by 14
Cantor, S. B., & Nayak, S. U. (2016) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2016.02.003 · Cited by 13
Increased levels of RECQ5 shift DNA repair from canonical to alternative pathways
Olson, H., Davis, L., Kiianitsa, K., Khoo, K. J., Liu, Y., Knijnenburg, T., & Maizels, N. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky727 · Cited by 13
Rieckhoff, J., Meyer, F. B., Classen, S., Zielinski, A., Riepen, B., Wikman, H., Petersen, C., Rothkamm, K., Borgmann, K., & Parplys, A. C. (2020) · Cancers · doi:10.3390/cancers12102809 · Cited by 13
Chromatin and Nuclear Dynamics in the Maintenance of Replication Fork Integrity
Wootton, J., & Soutoglou, E. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.773426 · Cited by 15
Metadata
- Authors
- Schlacher, K., Wu, H., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California, Los Angeles (US)
- Corresponding author
- Schlacher, Katharina
- Jasin, Maria
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 22
- Issue
- 1
- Pages
- 106-116
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3954744
- OpenAlex
- W2096380982
- Cited by
- 936
- References
- 46
- Citations by year
- 2026: 40 · 2025: 56 · 2024: 80 · 2023: 70 · 2022: 69 · 2021: 91 · 2020: 86 · 2019: 63 · 2018: 83 · 2017: 74 · 2016: 87 · 2015: 53 · 2014: 50 · 2013: 27 · 2012: 7
- FWCI
- 17.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA121110, P01-CA94060, P01CA094060)
- National Institute of General Medical Sciences (R01 GM54668, R01GM054668)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, replication fork protection, FANCD2, RAD51, BRCA1, BRCA2, DNA repair, epistasis, genomic instability, tumor suppression
- MeSH terms
- Cell Line, Transformed, DNA Replication, Fanconi Anemia, Humans, Genes, BRCA1, Genes, BRCA2, BRCA2 Protein, Genomic Instability, Rad51 Recombinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review